Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Remission of Refractory Celiac Disease With Infliximab in a Pediatric Patient.

Remission of Refractory Celiac Disease With Infliximab in a Pediatric Patient. ACG Case Rep J. 2015 Jan; 2(2):121-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.